Lynchburg Journal of Medical Science

Lynchburg Journal of Medical Science


Internal medicine


Vickie Beloy, DMSc, PA-C


The inpatient treatment of diabetic gastroparesis is difficult with few treatment options for patient management. Metoclopramide is the only FDA approved medication for the treatment of gastroparesis; however, this medication often fails to abate all of the symptoms of gastroparesis. Review of literature supports the consideration of adding haloperidol to inpatient gastroparesis treatment protocols, in addition to metoclopramide. Early addition of haloperidol for symptomatic gastroparesis control may help to improve a patient’s nausea, vomiting, and upper abdominal quadrant pain sooner than just metoclopramide alone.


Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.

Off-campus users can also use 'Off-campus Download' button above for access.